abstract |
The present application relates to novel substituted 4-arylimidazol-2-ones and 5-aryl-1,2,4-triazolones, methods for their preparation, their use alone or in combination in the treatment and / or prevention of diseases, and And their use for the manufacture of a medicament for the treatment and / or prevention of diseases, in particular cardiovascular diseases. |